SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Memecoin on Cronos launched by the Cro Crow community

crow with knife

Crow with knife is driving community excitement through its multi-chain presence and deflationary tokenomics, with supporters highlighting its organic growth and recent branding milestones. Investors are actively discussing the project's expansion across major blockchain ecosystems as they look for high-conviction opportunities in the meme coin sector.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi Technologies is trending after a sharp volatility spike triggered by a critical short-seller report from Muddy Waters, which alleged accounting irregularities and aggressive debt reporting. The community is actively discussing a massive V-shaped recovery and widespread suspicion of market manipulation, as CEO Anthony Noto responded immediately with significant insider share purchases while the firm vowed to explore legal action against the short sellers.

Swarmer, Inc. is an AI-driven software company, which develops software platforms and AI systems for autonomous swarm control of drones and unmanned vehicles. The firm offers STYX AI Command and Control System, MINAS Autonomy and Collaboration AI, and TRIDENT Embedded Drone Operating System. The company was founded by Alex Fink and Serhii Kuprienko in May 2023 and is headquartered in Austin, TX.

Swarmer Inc.

Swarmer Inc. is drawing significant attention after a strong IPO debut, with investors actively debating the potential of its combat-tested drone software amidst global defense demand. While many in the community are betting on explosive momentum and potential government contracts, others are urging caution, highlighting the company's limited revenue and the typical volatility associated with low-float IPOs.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon shares are facing downward pressure as investors weigh disappointing full-year earnings guidance and persistent leadership uncertainty amid a high-profile board reshuffle. The community remains divided, with some traders highlighting the stock's low valuation as a potential long-term entry point while others express concerns over increased competition and waning brand momentum.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is gaining attention as investors weigh promising preclinical data for its CDK9 inhibitor, SLS009, against anticipation for the long-awaited Phase 3 REGAL trial data. While the community is actively debating the potential for a transformative buyout or breakthrough survival outcomes in AML patients, skepticism remains among some participants regarding trial timelines, dilution, and the impact of the ongoing blindness of the data.

Monster Beverage Corp. is a holding company, which engages in the development, marketing, sale, and distribution of energy drink beverages and concentrates. It operates through the following segments: Monster Energy Drinks, Strategic Brands, and Other. The Monster Energy Drinks segment sells ready-to-drink packaged energy drinks to bottlers and full-service beverage distributors. The Strategic Brands segment sells concentrates and beverage bases to authorized bottling and canning operations. The Other segment consists of certain products sold by its subsidiary, American Fruits and Flavors LLC to independent third-party customers. The company was founded on April 25, 1990, and is headquartered in Corona, CA.

Monster Beverage Corp.

Monster Beverage is trending as investors weigh its resilient global growth and market leadership against ongoing analyst scrutiny and broader sector volatility. While the stock continues to benefit from strong brand loyalty and international expansion, the community is actively debating its valuation compared to high-growth challengers like Celsius.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo Inc. is currently facing significant volatility as investors weigh the company's recent NRC materials license win and DOE agreement against concerns over its pre-revenue status and impending quarterly financial disclosures. Community sentiment remains polarized, with some bulls highlighting long-term potential in AI-driven nuclear energy while bears express skepticism over insider selling and the extended timeline for operational deployment.

Verizon Communications, Inc. is a holding company, which engages in the provision of communications, information, and entertainment products and services. It operates through the Consumer and Business segments. The Consumer segment provides consumer-focused wireless and wire line communications services and products. The Business segment offers wireless and wireline communications services and products, including FWA broadband, data, video and conferencing services, corporate networking solutions, security and managed network services, local and long-distance voice services, and network access to deliver various IoT services and products. The company was founded in 1983 and is headquartered in New York, NY.

Verizon Communications Inc

Verizon Communications Inc.

Verizon is facing intense investor scrutiny following a major, nationwide network outage that impacted millions, with community debate centered on the effectiveness of offered account credits and the long-term impact on service reputation. Sentiment remains polarized, as bullish investors highlight the finalized Frontier Communications acquisition and high dividend yield as defensive strengths, while bears express concern over the company's massive debt load and the potential for a dividend reduction.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is currently trending as investors monitor its tight correlation with Bitcoin and shifting institutional sentiment regarding crypto-focused legislation. The community remains divided, with active debates focused on the stock's recent price volatility, potential technical breakout levels, and the company's long-term competitive position as a leading digital asset exchange.

Cronos is an institutional-grade, high-performance, EVM-compatible Layer-1 blockchain built on the Cosmos SDK and integrated with the Inter-Blockchain Communication (IBC) protocol, designed as the backbone for open, compliant, and AI-accessible tokenized markets. It supports up to 60,000 transactions per second (TPS), 500ms block times, instant finality, and sub-$0.01 fees via Proof of Authority consensus.

Crypto.com Coin

Crypto.com Coin (CRO) is capturing community attention as investors await potential ETF approvals and anticipate benefits from a strategic partnership in prediction markets, while native meme coins like crow with knife (CAW) and Mistery (MERY) continue to drive ecosystem volume. The community remains divided between long-term bullish sentiment regarding upcoming infrastructure upgrades and frustrations over historical price performance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Lowered to $131.00 at Citigroup

Citigroup cut their price target on shares of Rhythm Pharmaceuticals from $136.00 to $131.00 and set a "buy" rating on the stock in a report on Tuesday...

Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Lowered to $130.00 at Royal Bank Of Canada

Royal Bank Of Canada decreased their target price on Rhythm Pharmaceuticals from $140.00 to $130.00 and set an "outperform" rating for the company in a report on Tuesday...

Citizens Jmp Cuts Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target to $152.00

Citizens Jmp dropped their target price on Rhythm Pharmaceuticals from $176.00 to $152.00 and set a "market outperform" rating on the stock in a report on Tuesday...

Morgan Stanley Issues Pessimistic Forecast for Rhythm Pharmaceuticals (NASDAQ:RYTM) Stock Price

Morgan Stanley reduced their target price on shares of Rhythm Pharmaceuticals from $150.00 to $136.00 and set an "overweight" rating on the stock in a research note on Tuesday...

Needham & Company LLC Lowers Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target to $130.00

Needham & Company LLC cut their price objective on Rhythm Pharmaceuticals from $139.00 to $130.00 and set a "buy" rating for the company in a research report on Tuesday...

Rhythm Pharmaceuticals Rare Obesity Drug Study Disappoints

Rhythm Pharmaceuticals says EMANATE trial misses goals, despite BMI reduction signals and continued pipeline development plans.read more...

Rhythm Pharmaceuticals, Inc. $RYTM Shares Bought by Aquatic Capital Management LLC

Aquatic Capital Management LLC increased its holdings in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) by 974.9% during the third quarter, according to its most recent filing with the...

First Light Asset Management LLC Takes $18.23 Million Position in Rhythm Pharmaceuticals, Inc. $RYTM

First Light Asset Management LLC purchased a new position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) during the 3rd quarter, according to the company in its most recent disclosure...

598,247 Shares in Rhythm Pharmaceuticals, Inc. $RYTM Purchased by Capital Research Global Investors

Capital Research Global Investors acquired a new position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) in the 3rd quarter, according to the company in its most recent filing with the...

Rhythm Pharmaceuticals (NASDAQ:RYTM) CAO Sells 5,614 Shares

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Get Free Report) CAO Christopher Paul German sold 5,614 shares of the stock in a transaction on Wednesday, March 4th. The stock was sold at an average...

Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with rare diseases. The firm offers IMCIVREE (setmelanotide), a precision medicine designed to treat hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) diseases. It is also involved in the clinical development program for setmelanotide in other rare MC4R pathway diseases, as well as a preclinical suite of investigational candidates for the treatment of congenital hyperinsulinism. The company was founded by Bart Henderson in November 2008 and is headquartered in Boston, MA.

RYTM
Rhythm Pharmaceuticals Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest RYTM News

RYTMRhythm Pharmaceuticals Inc.